GR3005834T3 - - Google Patents
Info
- Publication number
- GR3005834T3 GR3005834T3 GR920402167T GR920402167T GR3005834T3 GR 3005834 T3 GR3005834 T3 GR 3005834T3 GR 920402167 T GR920402167 T GR 920402167T GR 920402167 T GR920402167 T GR 920402167T GR 3005834 T3 GR3005834 T3 GR 3005834T3
- Authority
- GR
- Greece
- Prior art keywords
- compound
- narcotic
- analgesic
- noroxymorphone
- methylnaltrexone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP87307999A EP0306575B1 (en) | 1987-09-10 | 1987-09-10 | Quaternary derivatives of noroxymorphone which relieve nausea and emesis |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3005834T3 true GR3005834T3 (el) | 1993-06-07 |
Family
ID=8198027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR920402167T GR3005834T3 (el) | 1987-09-10 | 1992-09-30 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0306575B1 (el) |
AT (1) | ATE78687T1 (el) |
DE (1) | DE3780819T2 (el) |
ES (1) | ES2051742T3 (el) |
GR (1) | GR3005834T3 (el) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274591B1 (en) * | 1997-11-03 | 2001-08-14 | Joseph F. Foss | Use of methylnaltrexone and related compounds |
ES2286461T3 (es) * | 2002-09-25 | 2007-12-01 | Euro-Celtique S.A. | Hidroformas n-substituidss y uso de las mismas. |
PL2368554T3 (pl) | 2003-04-08 | 2015-05-29 | Progenics Pharm Inc | Preparaty farmaceutyczne zawierające metylonaltrekson |
ES2714198T3 (es) | 2005-03-07 | 2019-05-27 | Univ Chicago | Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales |
US8524731B2 (en) | 2005-03-07 | 2013-09-03 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
US9662325B2 (en) | 2005-03-07 | 2017-05-30 | The University Of Chicago | Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
US8518962B2 (en) | 2005-03-07 | 2013-08-27 | The University Of Chicago | Use of opioid antagonists |
AR057325A1 (es) | 2005-05-25 | 2007-11-28 | Progenics Pharm Inc | Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos |
AR057035A1 (es) | 2005-05-25 | 2007-11-14 | Progenics Pharm Inc | SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS |
ES2765811T5 (es) | 2007-03-29 | 2024-02-27 | Progenics Pharm Inc | Forma cristalina de bromuro de (R)-n-metilnaltrexona y sus usos |
ES2540551T3 (es) | 2007-03-29 | 2015-07-10 | Wyeth Llc | Antagonistas de receptores opioides periféricos y usos de los mismos |
PE20090700A1 (es) | 2007-03-29 | 2009-07-13 | Progenics Pharm Inc | Compuestos heterociclicos como antagonistas del receptor opioide periferico |
WO2009099411A1 (en) | 2008-02-06 | 2009-08-13 | Progenics Pharmaceuticals, Inc. | Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone |
EP2278966B1 (en) | 2008-03-21 | 2019-10-09 | The University of Chicago | Treatment with opioid antagonists and mtor inhibitors |
CA2676881C (en) | 2008-09-30 | 2017-04-25 | Wyeth | Peripheral opioid receptor antagonists and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1202148A (en) * | 1968-03-06 | 1970-08-12 | Sankyo Co | Pharmaceutical compositions |
US4176186A (en) * | 1978-07-28 | 1979-11-27 | Boehringer Ingelheim Gmbh | Quaternary derivatives of noroxymorphone which relieve intestinal immobility |
US4466968A (en) * | 1980-11-24 | 1984-08-21 | Dermall, Ltd. | Method for prophylaxis or treatment of emesis and nausea |
JPS59500418A (ja) * | 1982-03-16 | 1984-03-15 | ザ ロツクフエラ− ユニバ−シテイ | 胃腸能動作用障害を回復する方法 |
-
1987
- 1987-09-10 EP EP87307999A patent/EP0306575B1/en not_active Expired
- 1987-09-10 AT AT87307999T patent/ATE78687T1/de not_active IP Right Cessation
- 1987-09-10 ES ES87307999T patent/ES2051742T3/es not_active Expired - Lifetime
- 1987-09-10 DE DE8787307999T patent/DE3780819T2/de not_active Expired - Lifetime
-
1992
- 1992-09-30 GR GR920402167T patent/GR3005834T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE3780819D1 (de) | 1992-09-03 |
EP0306575B1 (en) | 1992-07-29 |
ES2051742T3 (es) | 1994-07-01 |
EP0306575A1 (en) | 1989-03-15 |
DE3780819T2 (de) | 1993-01-14 |
ATE78687T1 (de) | 1992-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3005834T3 (el) | ||
Lewis et al. | The pharmacology and abuse potential of buprenorphine: A new antagonist analgesic. | |
ZA899028B (en) | Compound for treatment for autoimmune diseases | |
AU4519089A (en) | Device for aiding in preparation of intravenous therapy | |
HK1000913A1 (en) | Use of indolone derivatives for the preparation of medicaments for the treatment of parkinsons disease | |
IL76932A (en) | Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen | |
WO2001013909A3 (en) | Compositions and methods for treating opiate intolerance | |
EP0724885A4 (en) | COMPOSITION ADMINISTERED BY NASAL AND PREPARATION CONTAINING THE SAME | |
NO923859L (no) | Medikament | |
GB2206493B (en) | Inophoresis device for the percutaneous or perungual administration of a dissolved or partially dissolved substance | |
EP0296553A3 (en) | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter | |
NO894295L (no) | Fremgangsmaate for behandling av interstitiell cystitt. | |
ZA973444B (en) | Transdermally administered dextromethorphan as antitussive agents. | |
DE69332378D1 (de) | Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung | |
JPS6483020A (en) | Medicinal composition for preventing or treating aids | |
GR3025518T3 (en) | Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus | |
AU2908389A (en) | Device for administering medicaments by atomization in intubated or tracheotomized patients | |
AU1926988A (en) | Opioid analgesic liposomal delivery-release system | |
GR3018335T3 (en) | Use of a pure narcotic antagonist, e.g. nalmefene, naltrexone, naloxone or diprenorphine, in the treatment of mast cell disease. | |
GR900300082T1 (en) | Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine | |
FUJIWARA et al. | Effects of repeated administration of pentazocine on ambulatory activity in mice: comparison with the effects of morphine and methamphetamine | |
EP0282690A3 (en) | Treatment of rheumatoid arthritis with 3,5-dichloromethotrexate | |
KR870005642A (ko) | 디플루니살과 트로메타민의 혼합물 | |
UA30654A (uk) | Спосіб лікування посттравматичних дисфункцій висково- нижньощелепового суглоба | |
MX9603766A (es) | Metodos de administracion de benzamidas n-substituidas o fenotiazinas. |